KATHERINE GOODLOE: Open Payments
NPI 1811734635 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,615 in 55 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $839 · 2025 $1,615
Food & beverage: $1,516Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $371 |
| Astellas Pharma US Inc | 6 | $199 |
| Sumitomo Pharma America, Inc. | 8 | $189 |
| ACCORD HEALTHCARE, INC. | 1 | $116 |
| ABBVIE INC. | 2 | $108 |
| PFIZER INC. | 4 | $94 |
| PROGENICS PHARMACEUTICALS, INC. | 3 | $77 |
| UROGEN PHARMA, INC. | 2 | $67 |
| Ferring Pharmaceuticals Inc. | 3 | $62 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $56 |
Products named: ERLEADA, XTANDI, GEMTESA, RYBREVANT, Camcevi, BOTOX, PYLARIFY, JELMYTO.
Industry payments across AZ — which companies pay providers there.
